Decreased Rate of Presentation, but Worsened Racial-Ethnic Disparity in Acute Gastrointestinal Bleeding During

Sumana Reddy1, Beyla Patel2, Luke Baldelli3

  • 1Department of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

Insights

During COVID-19 stay-at-home orders, fewer gastrointestinal bleeding (GIB) cases presented to emergency departments. However, GIB cases that did present were more severe, particularly for minority patients.

Area of Science:

  • Gastroenterology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic and associated
  • stay-at-home
  • orders may have altered emergency condition presentations.
  • Gastrointestinal bleeding (GIB) is a significant emergent condition.

Purpose of the Study:

  • To compare the incidence and severity of GIB during the strictest COVID-19 lockdown period with pre-COVID periods.
  • To analyze demographic factors influencing GIB outcomes during the pandemic.

Main Methods:

  • Retrospective cohort study comparing weekly emergency department (ED) visits for GIB.
  • Data collected from March 27 to May 7, 2020 (COVID period) and compared to pre-COVID periods in 2019 and 2020.
  • Severity assessed by blood transfusion requirements, ICU admission, shock, and procedures.

Main Results:

  • Fewer ED visits for GIB occurred during the COVID period (534) compared to 2019 (904).
  • A higher proportion of COVID-period GIB visits resulted in inpatient admission (73.6%) and severe GIB (19.3%).
  • Patients during COVID experienced worse outcomes, including higher rates of transfusion, shock, and critical hemoglobin/lactate levels. Non-white patients showed disproportionately worse outcomes.

Conclusions:

  • The COVID-19 pandemic saw a decrease in GIB presentations but an increase in severity.
  • Minority populations experienced disproportionately worse GIB outcomes during the pandemic.
  • Public health interventions during pandemics may impact emergent condition care and outcomes.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
156
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
214
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
521
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
374
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
930
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
858